Startseite>>GPR81 agonist 1

GPR81 agonist 1

Katalog-Nr.GC61625

GPR81-Agonist 1 ist ein potenter und hochselektiver GPR81-Agonist mit EC50-Werten von 58 nM bzw. 50 nM fÜr menschliches bzw. Maus-GPR81.

Products are for research use only. Not for human use. We do not sell to patients.

GPR81 agonist 1 Chemische Struktur

Cas No.: 1620992-67-7

Größe Preis Lagerbestand Menge
5 mg
371,00 $
Auf Lager
10 mg
630,00 $
Auf Lager
50 mg
1.808,00 $
Auf Lager
100 mg
2.688,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

GPR81 agonist 1 is a potent and highly selective GPR81 agonist, with EC50s of 58 nM and 50 nM for human and mouse GPR81, respectively. GPR81 agonist 1 inhibits lipolysis in differentiated 3T3-L1 adipocytes. GPR81 agonist 1 suppresses lipolysis in mice without cutaneous flushing. GPR81 agonist 1 displays remarkable selectivity for GPR81 over GPR109a[1].

GPR81 agonist 1 (compound 2) (1-1000 nM) inhibits lipolysis in differentiated 3T3-L1 adipocytes[1].

GPR81 agonist 1 (100 mg/kg; i.p.) suppresses lipolysis in mice without cutaneous flushing[1].GPR81 agonist 1 (10 mg/kg; i.p.) shows good bioavailability (71%) and Cmax (6.3 μM)[1]. Animal Model: Nine-week-old male C57/Bl6 mice (fed and fasted mice)[1]

[1]. Sakurai T, et al. Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing. Eur J Pharmacol. 2014;727:1-7.

Bewertungen

Review for GPR81 agonist 1

Average Rating: 5 ★★★★★ (Based on Reviews and 18 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for GPR81 agonist 1

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.